Shigatoxin 2 Antibodies

Santa Cruz Biotechnology offers a broad range of Shigatoxin 2 monoclonal antibodies for research focused on understanding the mechanisms of this potent virulence factor. Shigatoxin 2 Antibodies are available for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Shigatoxin 2, produced by certain strains of Shigella bacteria, plays a significant role in the pathogenesis of shigellosis, a severe intestinal infection. The toxin functions by inhibiting protein synthesis in host cells, which leads to cell death and contributes to the inflammatory response associated with the disease. Understanding Shigatoxin 2 mechanisms is crucial for developing therapeutic strategies and interventions against Shigella infections. Researchers can explore the molecular pathways and cellular interactions influenced by Shigatoxin 2 through various experimental approaches. Advanced research techniques enable scientists to examine the toxin's effects on different cell types and tissue systems. Investigating the relationship between Shigatoxin 2 and host immune responses provides valuable information for potential therapeutic developments. Santa Cruz Biotechnology monoclonal antibodies support the scientific community by enabling precise and reliable investigation of Shigatoxin 2 in infectious disease research.